Why the study?
Heparin-induced thrombocytopenia affects patients exposed to heparin across diverse conditions, prompting evaluation of how patient age, unfractionated heparin dose, and nadir platelet count influence the 4T score.
Do patient age, unfractionated heparin dose, and nadir platelet count affect the 4T score in patients with heparin-induced thrombocytopenia?
Do patient age, unfractionated heparin dose, and nadir platelet count affect the 4T score in patients with heparin-induced thrombocytopenia?
Answers are grounded in this paper and cite their sources.
In a small case series of patients with HIT, patient age and nadir platelet count were significant predictors of the 4T score, whereas total unfractionated heparin dose was not.
Heparin-induced thrombocytopenia (HIT) is a condition that can affect patients who are exposed to heparin across a variety of disease states. A case series study was conducted to evaluate the effect of patient age, unfractionated heparin dose and nadir platelet count on the 4T score in a multiple regression analysis. The number of cases selected was ten. The regression analysis showed that patient age and nadir platelet count were statistically significant (P<.05) and the R-squared value was 0.7. A Pearson correlation coefficient analysis also revealed a low positive correlation between heparin dose and platelet count (r = 0.3). These findings add to the body of knowledge encompassing unfractionated heparin which remains a widely used anticoagulant for patients with thrombotic disease and other conditions and procedures. Future studies should continue to evaluate factors that affect HIT including outcomes between Type I and Type II HIT.
No takes yet. Share an insight, caveat, or question.
Hughes VC (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: